Table 1

Medication possession ratio

MeasureGLMADAETACZPp Value versus GLM
N68314001765187
MPR, mean (SD)0.90 (0.14)0.85 (0.18)0.84 (0.20)0.84 (0.16)<0.0001*
MPR ≥0.80, n (%)595 (87%)1044 (75%)1285 (73%)132 (71%)<0.0001†
  • *p Value obtained from one-way analysis of variance for multiple means comparison.

  • †p Value obtained from χ2 and pair-wise comparison tests for statistical differences on the proportion of high adherent patients.

  • ADA, adalimumab; CZP, certolizumab pegol; ETA, etanercept; GLM, golimumab; MPR, medication possession ratio.